People Will Become More Accepting Of Jabs: Expert
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576240_1_20210218165956.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 17:16
Dr Leung Chi-chiu speaks to Wendy Wong
A specialist in respiratory medicine said on Thursday that he believed more people would be willing to receive coronavirus vaccine once the inoculation programme is rolled out, although various surveys suggested a low acceptance rate.
Previous polls showed only between 30 and 40 per cent of Hong Kong people would get the jabs, but Dr Leung Chi-chiu said he believed their attitude would change over time.
He said he expected the public to become less worried about the vaccine’s safety as more people get inoculated.
“For something new, I think the initial acceptance may be low. That should not be a major issue because the priority groups account for about 2.4 million people. And we only have sufficient vaccine in the initial stage for one million,” he said.
“If we can roll out the programme successfully, I’m certain that the attitude will change with time. As time goes, there will be further data not only from abroad but also from the local application. That should relieve the anxiety of people who might be worried about the vaccine’s safety profile.”
He noted that an expert panel appointed by the government has yet to decide on whether the vaccine produced by mainland drug maker Sinovac can be given to elderly people aged over 60.
He said the decision would affect how quickly protection could be offered to elderly people living in care homes here.
“This is crucial because this vaccine does not require the super cold storage syringe. They can be more easily handled by the outreach teams. If they can be applied for the elderly, they can be quickly utilised to cover our old age homes,” he said.
Ping An P&C And FAW Hongqi Launch Hongqi Intelligent Driving Protection Services
Ping An Property & Casualty Insurance Company of China (Ping An P&C), a subsidiary of Ping An Insurance, has pa... Read more
HKSTP European Innovation Mixer Tour Nurtures Global Ties For Hong Kong
The Hong Kong Science and Technology Parks Corporation (HKSTP), led by CEO Albert Wong, conducted the HKSTP European In... Read more
The Full List Of Fintech Unicorns In Hong Kong (2025)
Hong Kong’s fintech landscape has evolved into a dynamic force in Asia, driven by regulatory innovation, technologica... Read more
HKSTPs EPIC 2025 Competition Returns, Doubling Investment Pool To US$100M
The 9th edition of the Elevator Pitch International Competition, also known as the EPIC 2025 competition, officially op... Read more
RedotPay Secures $40 Million Series A Funding, To Advance Global Crypto Payment Solutions
RedotPay secures $40 million Series A funding, marking a major milestone for the crypto payment platform. The announcem... Read more
BOOM Hits $2 Billion In AUM, Reinvesting Into Crypto And Tokenised Securities
BOOM, a Hong Kong-based online investing platform for high-net-worth individuals, announced on 12 March 2025 that it ex... Read more